Skip to main content
US EQUITIES PRE-MARKET CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
NT

NTRAStockNatera Inc

Nasdaq Global Select Market · Healthcare · US

$289.50 last close 2026-11-18
Open in terminalCompare
Price alert

Verdicts genuinely change. Free email alert the moment NTRA's does — no target price to set, unlike a price alert.

Stable Ratio screen, 4 of 7 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it

Sharia status
COMPLIANT
Per our secondary compliance provider · assessed 2026-08-12
4 of 7 pass our own screen — the standards disagree
🕌 Held by MNZL HTR non-permissible income <0.01%
🕌Open research, not a fatwa — verify with your own scholar.

Trade setup

Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.

SEPARATE FROM SHARIAH
🔴 AVOID
The main driver: lagging the market by 26.0%, insider selling on the open market. Too many signals pointing the...
Scores: 1 bullish / 4 bearish
36
of 100
Setup confidence — system conviction, not win probabilityD

Trade plan

Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.

VWAP · SCALP
Entry
$388.57
Stop
$383.18
Target
$399.35
Risk : Reward 2.0R

Why this signal?

The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.

Structure2 of 5 timeframes bullish · 43.5% aligned
VWAPPrice below VWAP ($297.30)
VolumeRelative volume 3.7× the 20-day average
Momentum10-day rate of change -27.3%
Overall readAVOID

Natera Inc (NTRA) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-12). See the full ratio breakdown and business-activity screen below for the reasoning.

This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →

Market & analysts
Wall Street consensus
BUY
30 analysts
Institutional own.
96.8%
of shares
Momentum (10d)
-27.3%
rate of change
SMC grade
D · 36
43.5% aligned
🕌 MNZL
Held by real halal ETF(s)
<0.01%
Non-permissible income — HTR, from filings (2026-06-30)
D · 36
SMC grade — 43.5% timeframe alignment
-27.3%
Rate of change (10d)
BUY
Wall Street consensus (30)
96.8%
Institutional ownership

How the status reached this point

Compliant · status tracked since Nov 17, 2026

No change to NTRA’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.

Read once a day from our own screen, last on Nov 18, 2026. The per-methodology record is under “What changed, and when” in the in-house research.

Free email, sent when our compliance re-scan finds a change.

🕌 In-house Compliance Research

Computed from published company financials, balance sheet as of 2026-09-30. These ratios come from the issuer's own published statements rather than structured SEC data.

AAOIFI divides by the market cap: $41.7B as of 2026-11-18.

Business activity: cleared (no excluded categories detected)

AAOIFI Pass 3 of 3 ratios pass
RatioValueThresholdResult
Interest-bearing debt 0.57% 30.00% Pass(29.4pp buffer)
Interest-bearing investments 2.63% 30.00% Pass(27.4pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Usmani Fail 3 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 8.69% 33.00% Pass(24.3pp buffer)
Interest-bearing investments 39.92% 33.00% Fail(6.9pp over)
Non-liquid assets 42.93% at least 20.00% Pass(22.9pp above the floor)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
MSCI Fail 2 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 8.69% 33.33% Pass(24.6pp buffer)
Cash + interest-bearing securities 39.92% 33.33% Fail(6.6pp over)
Accounts receivable 57.07% 33.33% Fail(23.7pp over)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
FTSE Fail 2 of 4 ratios pass
RatioValueThresholdResult
Interest-bearing debt 2.92% 33.33% Pass(30.4pp buffer)
Cash + interest-bearing securities 39.92% 33.33% Fail(6.6pp over)
Accounts receivable 57.07% 50.00% Fail(7.1pp over)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
Dow Jones Islamic Market Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 0.80% 33.00% Pass(32.2pp buffer)
Cash + interest-bearing securities 3.66% 33.00% Pass(29.3pp buffer)
Accounts receivable 1.57% 33.00% Pass(31.4pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
S&P Shariah Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 1.00% 33.00% Pass(32.0pp buffer)
Cash + interest-bearing securities 4.59% 49.00% Pass(44.4pp buffer)
Accounts receivable 1.97% 49.00% Pass(47.0pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)
MSCI M-Series Pass 4 of 4 ratios pass

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 1.00% 33.33% Pass(32.3pp buffer)
Cash + interest-bearing securities 4.59% 33.33% Pass(28.7pp buffer)
Accounts receivable 6.56% 49.00% Pass(42.4pp buffer)
Non-permissible income 0.00% 5.00% Pass(5.0pp buffer)

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

How close is it to flipping?

Every current reading against its own line, closest first. A verdict is only as durable as that distance.

AAOIFI Standard 21 (% of market cap)non permissible income ratio 5.0pts
Usmani (% of total assets)non permissible income ratio 5.0pts
Dow Jones Islamic Market (% of 24-mo avg market cap)non permissible income ratio 5.0pts
MSCI Islamic Index (% of total assets)receivables ratio 23.7pts
FTSE Shariah Global Equity Index Series (% of total assets)receivables ratio 7.1pts
Usmani (% of total assets)investments ratio 6.9pts

The numbers the ratios are built from

Read from NTRA's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.

LineFigureAs reportedRead from
RevenueTotal revenue for the period $2.3B 2026-09-30 RevenueFromContractWithCustomerExcludingAssessedTax
Interest-bearing debtShort and long-term borrowings $80.3M 2026-09-30 ShortTermBorrowings
Cash and interest-bearing securitiesCash, equivalents and marketable securities $1.1B 2026-09-30 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
Total assetsBalance sheet total $2.7B 2026-09-30 Assets
Market capDenominator for AAOIFI $41.7B live quote price x shares
36-month average market capDenominator for S&P Shariah and MSCI M-Series $23.8B 756 trading days closes x shares
24-month average market capDenominator for Dow Jones Islamic Market $29.8B 504 trading days closes x shares
Non-permissible revenueInterest and excluded income $0 2026-09-30 no interest-income tag reported in 3+ years (treated as $0)

Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.

Sources

Filing information. Balance sheet: Quarterly report (10-Q) filed 2026-11-05, period ended 2026-09-30. Income statement: Annual report (10-K) filed 2026-02-27, period ended 2026-09-30. Screened 2026-11-18.

  • Total assets$2.7B
    Assets · period ended 2026-09-30 · 10-Q filed 2026-11-05
  • Interest-bearing debt$80.3M
    ShortTermBorrowings · period ended 2026-09-30 · 10-Q filed 2026-11-05
  • Cash and interest-bearing securities$1.1B
    CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · period ended 2026-09-30 · 10-Q filed 2026-11-05
  • Receivables$471.4M
    AccountsReceivableNetCurrent · period ended 2026-09-30 · 10-Q filed 2026-11-05
  • Revenue$2.3B
    RevenueFromContractWithCustomerExcludingAssessedTax · period ended 2025-12-31 · 10-K filed 2026-02-27
  • Interest income (non-permissible)$0
    no interest-income tag reported in 3+ years (treated as $0) · income statement as of 2026-09-30 · no filing link for this figure
  • Market cap$41.7B
    Market quote passed in by the screen (Finnhub company profile; Yahoo Finance where Finnhub has none), 2026-11-18 · not a filing figure, so no link

5 reported values cited from 2 SEC filings, read from SEC's XBRL company facts when this symbol was screened. A link opens the filing's index on EDGAR.

What changed, and when

Verdict history for NTRA. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.

  • 2026-09-07 No change recorded No verdict change for NTRA has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.

Tracked since 2026-09-07.

What would change the status

The headline verdict is the majority of the decided ratio standards — 4 pass and 3 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-30; market cap as stored on 2026-11-18.

No standard's deciding ratio sits within 3 points of its line.

The ratios that move with the share price

AAOIFI's debt ratio (0.6% against a 30% line) would only fail if the market cap fell by 98%, to $796.1M.

AAOIFI's investments ratio (2.6% against a 30% line) would only fail if the market cap fell by 91%, to $3.7B.

Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.

Shariah-compliant alternatives

Compliant companies in Diagnostics & Research listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.

CompanyMarket capPrice, day
DHRDanaher Corp. $146.0B —
IDXXIdexx Laboratories, Inc. $44.1B —
AAgilent Technologies Inc. $43.3B —
WATWaters Corp. $37.3B —
ILMNIllumina Inc $33.7B —

A dash means no fresh quote is cached for that symbol; this list does not fetch one.

Funds that hold NTRA

18 of the 205 funds whose filed holdings we currently hold own NTRA shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns NTRA.

Shariah funds
FundNTRA in fundFund compliant by weight
MNZL Manzil Russell Halal USA Broad Market ETF 0.12% 88%
You may already own it

Widely held U.S. index funds. If you own one, you own NTRA through it. None of them is a Shariah fund; the last column is our look-through of each.

FundNTRA in fundFund compliant by weight
IWF iShares Russell 1000 Growth ETF 0.11% 69%
SCHB Schwab U.S. Broad Market ETF 0.06% 53%
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.05% 54%
VTI VANGUARD TOTAL STOCK MARKET INDEX FUND 0.05% 54%
Other funds
FundNTRA in fundFund compliant by weight
RSMOX Victory RS Mid Cap Growth Fund 1.82% 60%
SUHAX DWS Health and Wellness Fund Also SUHCX 0.54% 83%
JPPEX JPMorgan Mid Cap Equity Fund 0.48% 42%
SWHFX Schwab Health Care Fund 0.41% 76%
ROUS Hartford Multifactor US Equity ETF 0.35% 53%
SWLGX Schwab U.S. Large-Cap Growth Index Fund 0.11% 66%
RTDCX Multifactor U.S. Equity Fund 0.10% 52%
SFY SoFi Select 500 ETF 0.08% 61%
FBALX Fidelity Balanced Fund 0.06% not computed
DFUS Dimensional U.S. Equity Market ETF 0.05% 53%
3 more funds
FundNTRA in fundFund compliant by weight
CRBN iShares Low Carbon Optimized MSCI ACWI ETF 0.04% 50%
VTWAX VANGUARD TOTAL WORLD STOCK INDEX FUND 0.03% 50%
SAOOX Overlay A Portfolio 0.03% not computed

Sorted by NTRA’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names NTRA once, so a bond is not counted as the shares; 3 more funds name NTRA in a way we cannot separate from its bonds, and are not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.

Tracked investors holding NTRA
InvestorFirmPositionWeightAs of
Stanley Druckenmiller Duquesne Family Office $1,306M 29.2% 2026-09-30
Philippe Laffont Coatue Management $1,004M 1.8% 2026-09-30
David Shaw D. E. Shaw & Co. $521M 0.2% 2026-09-30
Lee Ainslie Maverick Capital $299M 2.3% 2026-09-30
Cathie Wood ARK Investment Management $226M 1.3% 2026-09-30
Ken Griffin Citadel Advisors $174M 0.0% 2026-09-30
Israel Englander Millennium Management $58M 0.0% 2026-09-30
Joel Greenblatt Gotham Asset Management $48M 0.1% 2026-09-30
Paul Tudor Jones Tudor Investment Corp $44M 0.1% 2026-09-30
Ray Dalio Bridgewater Associates $11M 0.0% 2026-09-30
Azzad Asset Management Azzad Asset Management $3M 0.3% 2026-09-30
Jefferies Jefferies Financial Group $3M 0.0% 2026-09-30
Torray Investment Partners Torray Investment Partners $3M 0.3% 2026-09-30
Ron Baron Baron Capital (BAMCO) $1M 0.0% 2026-09-30

From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.

436.00372.66309.32245.99182.652025-11-192026-05-212026-11-18

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
257.70
S2
267.46
S1
277.47
PIVOT
287.23
R1
297.24
R2
307.00
R3
317.01

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

7-day expected range
371.89 – 448.81
±9.37% from 410.35, made 2026-10-04 · resolves 2026-10-11
STRONG BUY
from 19 indicators
78.7% of our last 25417 forecasts — across every instrument we forecast, not just this one — landed inside their stated range, and 53.4% called the direction correctly.

Technical Summary

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

STRONG SELL
19 indicators
OscillatorsBUY
4 buy · 0 neutral · 3 sell
Moving averagesSTRONG SELL
1 buy · 0 neutral · 11 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)29.10BUY
Stochastic %K (14)7.97BUY
CCI (20)-106.47BUY
Williams %R (14)-92.03BUY
MACD (12,26,9)-9.22SELL
ROC (10)-25.96SELL
Momentum (10)-101.53SELL
EMA (10)317.41SELL
SMA (10)313.41SELL
EMA (20)342.50SELL
SMA (20)359.42SELL
EMA (30)353.64SELL
SMA (30)372.84SELL
EMA (50)356.16SELL
SMA (50)377.35SELL
EMA (100)335.04SELL
SMA (100)336.02SELL
EMA (200)291.45SELL
SMA (200)272.24BUY

About Natera Inc

Healthcare · Diagnostics & Research

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.

natera.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

Latest Signal — 2026-11-03

VWAP
Type · SCALP
388.57
Entry
383.18
Stop
399.35
Target
LOSS
Outcome · exit 383.18 (-1.39%)

Stop 383.18 Now 289.50 Target 399.35

Verdict

🔴 AVOID

The main driver: lagging the market by 26.0%, insider selling on the open market. Too many signals pointing the wrong way. Wait for the picture to improve before committing capital.

Scores: 1 bullish / 4 bearish

Grade verdict

Weak — low conviction, small size or skip

SMC — Top Down

Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.

TimeframeBiasBars
📅 Daily BEARISH 64
⏰ 4H RANGING 45
🕐 1H RANGING 98
⏱ 15-Min BULLISH 130
⏲ 5-Min BULLISH 234

Momentum & Volume

Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.

-27.3%
Rate of change (10d)
3.7×
Volume vs its 20-day average
-26.75
MACD (no fresh cross)

Peer Movement

How the rest of the sector moved over the same window. Context for a price move, never a cause of one.

Peer movement computing — it will appear here on its own.

Before you act on this

The questions worth asking about any verdict on this page, answered plainly.

Is this a fatwa?

No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.

Why can the standards disagree?

Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.

How often is this re-screened?

Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.

Do I need to purify dividends?

If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.

Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.

Compare with

Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.

Peer screening computing — it will appear here on its own.

Insider Activity (90d)

Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.

CLUSTER SELL   0 buys · 120 sells

Recent: Rabinowitz Matthew sold 2275394 sh @ $267.99 (2026-08-03); Rabinowitz Matthew sold 2276125 sh @ $260.49 (2026-07-27); Rabinowitz Matthew sold 2327843 sh @ $219.36 (2026-06-12)

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.

NEUTRAL   report date 2026-11-10 · Asset managers net 914130 (-14454)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.